Mednet Logo

How would you manage a patient with low-volume non-invasive endometrioid carcinoma that is found in both the endometrium and ovary (pN0)?

Would you approach this situation as synchronous primaries (eg. FIGO IA in both) or as a locally advanced endometrial cancer (FIGO IIIA)? What adjuvant therapy would you recommend?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Radiation Oncology And Cyberknife Treatment Ctr
Answered on

Isolated ovarian involvement in endometrial cancer is uncommon, and previous data from the Gynecologic Oncology Group and other single-institution series suggest that it occurs in less than 5% of patients. (Creasman et al. Cancer, 1987; Lin et al. Gynecol Oncol, 2015) Adnexal involvement when presen...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

The data suggest most of these patients in absence of adverse factors are/behave like synchronous two primary rather than metastatic disease Sometimes LOH analysis can also help distinguish metastatses vs. two primary. Our approach in absence of adverse factor (deep myometrial involvement, LVSI) is ...

Join for free or sign in to see the full answer